1. India Stocks

  2. •

    Consumer Cyclical

  3. •

    Packaging & Containers
Caprihans India Limited

Caprihans India Limited

CAPRIHANS.BO
Caprihans India LimitedIN flagBombay Stock Exchange
74.35
INR
+0.15
- -
1.09BMarket Cap
Caprihans India Limited
CAPRIHANS.BO
(Bombay Stock Exchange)

Recent

price

74.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
142.62
148.39
167.95
184.22
192.47
181.92
173.82
188.83
202.97
218.43
223.47
603.12
703.53
528.8
544.73
- -
479.59
Revenue per Share
5.65
5.43
5.17
4
5.37
4.15
7.35
3.15
2.79
7
15.4
-30.13
54.64
-39.3
-46.26
- -
-32.12
Basic EPS, GAAP
-6.51
2.08
5.71
4.23
8.12
7.74
-8.37
0.93
-2.06
5.35
3.44
4.66
-40.31
-40.73
72.69
- -
- -
Free Cash Flow per Basic Share
2.92
1.74
1.74
1.75
1.75
1.5
1.5
1.5
1.5
0.75
0.01
0.02
0.02
0.02
0.15
- -
- -
Dividend per Share
10
25.35
28.39
30.25
36.39
38.3
43.95
45
45.75
51.63
67.18
69.26
86.73
60.16
27.71
- -
10.87
Book Value per Share
73.68
77.36
80.22
82.43
88.34
90.06
96.06
97.45
98.63
104.92
120.53
-239.43
258.6
219.43
201.33
- -
268.28
Tangible Book Value per Share
13
13
13
13
13
13
13
13
13
13
13
13
13
13
14
- -
15
Basic Weighted Avg Shares
1,873
1,949
2,206
2,420
2,528
2,389
2,283
2,480
2,666
2,869
2,935
7,921
9,240
6,945
7,378
7,019
7,019
Sales/Revenue/Turnover
-6.3
4.26
3.6
2.29
3.59
5.96
4.07
1.38
1.09
3.11
7.21
3.48
3.46
0.14
-0.93
-0.46
-0.61
Operating Margin (%)
35
34
34
35
34
35
34
34
34
38
36
341
333
430
420
426
449
Depreciation Expense
74
71
68
53
71
54
97
41
37
92
202
-396
718
-516
-627
-470
-470
Net Income, GAAP
34.46
33.15
34.65
35.17
35.14
48.85
34.44
29.15
20.65
23.31
22.11
- -
31.87
- -
- -
- -
- -
Effective Tax Rate (%)
3.96
3.66
3.08
2.17
2.79
2.28
4.23
1.67
1.37
3.21
6.89
-5
7.77
-7.43
-8.49
-6.7
-6.7
Profit Margin (%)
744
768
840
890
939
929
1,048
1,027
1,023
1,119
1,319
-2,227
-125
-31
-698
84
84
Working Capital
5
5
- -
- -
- -
- -
1
2
- -
- -
- -
5,440
5,066
5,359
4,526
4,822
4,822
LT Debt
973
1,020
1,058
1,087
1,171
1,201
1,275
1,294
1,307
1,385
1,590
-3,050
5,392
4,882
4,320
4,039
4,039
Total Equity
-8.14
5.54
4.98
3.35
5.16
5.99
4.91
1.93
1.84
5.3
11.45
- -
2.78
- -
- -
- -
- -
Return on Invested Capital (%)
55.43
30.1
19.1
13.65
16.12
11.13
17.52
6.84
6.03
15.34
25.96
- -
12.87
- -
- -
- -
24.08
Return on Capital (%)
56.49
30.75
19.24
13.64
16.11
11.1
17.87
7.09
6.14
14.38
25.92
-44.17
70.05
-53.51
-107.52
-175.9
-175.94
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2,078
- -
1,602
LT Borrowings
4,683
- -
4,660
LT Finance Leases
168
- -
161
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
- -
16
Market Capitalization
1,823
1,301
783

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
3,046
- -
2,938
Cash, Cash Equivalents & STI
756
- -
475
Accounts Receivable, Net
1,088
- -
1,039
Inventories
1,064
- -
1,147
Total Current Liabilities
3,249
- -
2,855
Payables & Accruals
- -
- -
- -
ST Debt
2,078
- -
1,602
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-56.67%
-119.22%
-6.49%
Free Cash Flow
-223.45%
-239.6%
13.53%
Net Income, GAAP
-47.29%
-150.51%
-24.99%
Sales/Revenue/Turnover
18.46%
32.61%
-4.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,688
1,766
1,611
1,880
6,945
2025
1,782
1,887
1,878
1,831
7,378
2026
1,778
1,716
1,723
1,801
7,019

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-8.13
-7.15
-10.39
- -
-39.3
2025
-13.41
-21.59
-14.13
1.65
-46.26
2026
-9.27
-17.02
-10.67
4.8
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.15
2026
- -
- -
- -
- -
- -
Similar Companies
TriMas Corporation (TRS)
Smurfit Westrock PLC (SWR.L)
Sealed Air Corporation (0L4F.L)
Amcor plc (AMCR)
Madame Bioscience Public Company Limited (GLOCON.BK)
Anhui Genuine New Materials Co.,Ltd. (603429.SS)
Business
Caprihans India Limited Caprihans India Limited manufactures rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC)-coated films, aluminum foils, and plastic extruded products including PP corrugated sheets under the Sunpac brand for pharmaceutical, food, FMCG, packaging, advertising, and industrial applications; its product portfolio encompasses specialized brands such as Duplex, Triplex, Ultra Tx, Armour, Aclar, Excel, Venus, Zeon, Zenith, Crispak, and Lamiflex tailored for oral solid dosage pharmaceutical packaging, healthcare solutions like PPE hazmat coveralls, hospital linens, curtains, face shields, and portable beds, as well as alu alu films and other polymer-based packaging materials. Incorporated in 1946 and listed on the Bombay Stock Exchange since 1976, the company, promoted by Bilcare Mauritius Limited, operates manufacturing facilities in Pune, Nashik, and Thane in Maharashtra, India, with its registered office at 1028 Shiroli, Rajgurunagar, Pune, and primary operations serving domestic and export markets including pharmaceutical and food industries across India and internationally. In recent developments, Caprihans India Limited completed the acquisition of the Pharma Packaging Innovations (PPI) unit assets from its holding company Bilcare Limited in March 2023 for a net consideration of Rs. 213 crore, assuming liabilities of Rs. 620 crore through bank borrowings to enable backward integration for base film production and reduce import dependence; additionally, it incorporated a wholly owned subsidiary, Bilcare Research GmbH, in Germany on September 9, 2024, with initial share capital of EUR 25,000 to focus on sales and marketing of PVC-based films and aluminum foils for pharmaceutical packaging.